Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting
Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...
Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
Le Lézard13h
Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren's disease study
Nipocalimab was granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease based on results from the Phase 2 DAHLIAS study ...
Finanznachrichten14h
Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results
production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-based protein expression system, today reported financial results for the ...
Le Lézard14h
Nasoya Introduces Tofie, World's First AI-Powered Tofu Chatbot
Nov. 14, 2024 /PRNewswire/ -- Nasoya, the nation's leading brand of tofu and pioneer in plant-based foods, today announces a new culinary ... including seven accepted abstracts for poster presentation ...